Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat in Niemann-Pick Type C
NCT01760564Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of miglustat in Niemann-Pick disease type C (NPC), sponsored by National Taiwan University Hospital. Primary endpoint: Swallowing function at 12 months. Started Jan 2008; status: completed.
02
Drugs
miglustat
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on NCT01760564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760564.